NRG GY037: Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab VS Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High-Risk Locally Advanced Cervical Cancer
Cervical Cancer
Recruiting
Multiple locations
Disease: Cervical Cancer
Eligibility Criteria: None
NCT: 07061977
Inclusion:
-
Locally advanced with T3 or T4 disease with/without LN involvement
-
IIIA-IVA
-
No prior hysterectomy
-
No paraaortic LN mets above T12/L1
-
No prior definitive surgical, radiation, systemic tx, IO or pelvic radiation
Have questions about participation?
Our clinical research team is happy to answer questions about eligibility, the study process, or next steps.
Contact the Research Team